348 related articles for article (PubMed ID: 38229501)
1. Research progress on mitochondria regulating tumor immunity.
Li J; Xu P; Chen S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):1-14. PubMed ID: 38229501
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance.
Pandey S; Anang V; Schumacher MM
Int Rev Cell Mol Biol; 2024; 386():223-247. PubMed ID: 38782500
[TBL] [Abstract][Full Text] [Related]
3. Role of mitochondrial alterations in human cancer progression and cancer immunity.
Wang SF; Tseng LM; Lee HC
J Biomed Sci; 2023 Jul; 30(1):61. PubMed ID: 37525297
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria.
Bai R; Cui J
Cancer Lett; 2023 Jun; 564():216223. PubMed ID: 37172686
[TBL] [Abstract][Full Text] [Related]
5. AMPK-a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Wang N; Wang B; Maswikiti EP; Yu Y; Song K; Ma C; Han X; Ma H; Deng X; Yu R; Chen H
Cell Death Discov; 2024 May; 10(1):237. PubMed ID: 38762523
[TBL] [Abstract][Full Text] [Related]
6. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
Shen Q; Xu P; Mei C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles.
Cheng AN; Cheng LC; Kuo CL; Lo YK; Chou HY; Chen CH; Wang YH; Chuang TH; Cheng SJ; Lee AY
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268351
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
9. [Mitochondrial DNA and cGAS-STING Innate Immune Signaling Pathway: Latest Research Progress].
Li YX; Cui SF; Meng W; Hu HY; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):387-395. PubMed ID: 34018355
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial metabolic reprogramming: An important player in liver cancer progression.
Jin T; Wang C; Tian Y; Dai C; Zhu Y; Xu F
Cancer Lett; 2020 Feb; 470():197-203. PubMed ID: 31783085
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
13. The critical roles of STING in mitochondrial homeostasis.
Zou S; Wang B; Yi K; Su D; Chen Y; Li N; Geng Q
Biochem Pharmacol; 2024 Feb; 220():115938. PubMed ID: 38086488
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria in innate immune signaling.
Banoth B; Cassel SL
Transl Res; 2018 Dec; 202():52-68. PubMed ID: 30165038
[TBL] [Abstract][Full Text] [Related]
15. cGAS-STING signaling in the tumor microenvironment.
Liu Z; Wang D; Zhang J; Xiang P; Zeng Z; Xiong W; Shi L
Cancer Lett; 2023 Nov; 577():216409. PubMed ID: 37748723
[TBL] [Abstract][Full Text] [Related]
16. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
Wu D
Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
Dai E; Zhu Z; Wahed S; Qu Z; Storkus WJ; Guo ZS
Mol Cancer; 2021 Dec; 20(1):171. PubMed ID: 34930302
[TBL] [Abstract][Full Text] [Related]
18. A Mitochondria-Targeted NIR-II AIEgen Induced Pyroptosis for Enhanced Tumor Immunotherapy.
Yu K; Ye B; Yang H; Xu X; Mao Z; Zhang Q; Tian M; Zhang H; Zhang H; He Q
Adv Healthc Mater; 2023 Nov; 12(29):e2301693. PubMed ID: 37285905
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and tumor metabolic reprogramming.
López-Sánchez LM; Aranda E; Rodríguez-Ariza A
Biochem Pharmacol; 2020 Jun; 176():113769. PubMed ID: 31862448
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: Potential role in Sjögren's syndrome.
Barrera MJ; Aguilera S; Castro I; Carvajal P; Jara D; Molina C; González S; González MJ
Autoimmun Rev; 2021 Aug; 20(8):102867. PubMed ID: 34118452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
